Combination therapy of S-1 and CDDP for patients with colorectal cancer

We evaluate the feasibility and efficacy of S-1 in combination with cisplatin (CDDP) for patients with colorectal cancer. A total of 52 patients with advanced or recurrent colorectal cancer were included. S-1 was given orally twice daily for 21 days and CDDP 30 mg/m2 on day 1 and 8, followed by a 2-week period of no treatment. Tumor responses among patients… (More)